Omnicell (OMCL) Retained Earnings (2010 - 2026)
Omnicell's (OMCL) quarterly Retained Earnings came in at $1.3 billion in Q2 2026, up 4.59% year-over-year from $1.2 billion in Q2 2025, and up 0.9% quarter-over-quarter from $1.2 billion in Q1 2026.
Analysis
Omnicell (OMCL) Retained Earnings (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Retained Earnings for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Retained Earnings rose 4.59% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 4.59% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 4.8% from the prior year.
- Retained Earnings was $1.3 billion for Q2 2026 at Omnicell, up from $1.2 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $1.3 billion in Q2 2026 and troughed at $982.7 million in Q1 2022.
- A 5-year average of $1.1 billion and a median of $1.1 billion in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings advanced 2.16% in 2022 and grew 9.16% in 2023, its largest moves.
- Over 5 years, Retained Earnings stood at $1.0 billion in 2022, then climbed by 7.22% to $1.1 billion in 2023, then rose by 4.06% to $1.2 billion in 2024, then climbed by 4.8% to $1.2 billion in 2025, then increased by 2.16% to $1.3 billion in 2026.
- The last three Retained Earnings figures came in at $1.3 billion (Q2 2026), $1.2 billion (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 6.84 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 33.19 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 21.82 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 7.82 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 14.86 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 21.58 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 2.88 Bn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 7.26 Bn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 1.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.25 Bn |
| Mar 31, 2026 | 1.24 Bn |
| Dec 31, 2025 | 1.22 Bn |
| Sep 30, 2025 | 1.21 Bn |
| Jun 30, 2025 | 1.20 Bn |
| Mar 31, 2025 | 1.19 Bn |
| Dec 31, 2024 | 1.17 Bn |
| Sep 30, 2024 | 1.16 Bn |
| Jun 30, 2024 | 1.15 Bn |
| Mar 31, 2024 | 1.14 Bn |
| Dec 31, 2023 | 1.12 Bn |
| Sep 30, 2023 | 1.11 Bn |
| Jun 30, 2023 | 1.09 Bn |
| Mar 31, 2023 | 1.07 Bn |
| Dec 31, 2022 | 1.05 Bn |
| Sep 30, 2022 | 1.03 Bn |
| Jun 30, 2022 | 997.91 Mn |
| Mar 31, 2022 | 982.68 Mn |
| Dec 31, 2021 | 1.02 Bn |
| Sep 30, 2021 | 1.00 Bn |